According to the latest financial report of Neuroscientific Biopharmaceuticals Ltd, the latest earnings per share (TTM) for the company is --. Investing in companies with strong earnings per share can potentially provide higher returns.
Interested in knowing about Neuroscientific Biopharmaceuticals Ltd's free cash flow? The latest report shows it as --. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Neuroscientific Biopharmaceuticals Ltd shows that the company's current ratio is 58.87, indicating healthy liquidity.
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Neuroscientific Biopharmaceuticals Ltd, the quick ratio is 58.46, indicating that the company can meet its short-term debt obligations.
Want to learn more about the financial health of Neuroscientific Biopharmaceuticals Ltd? The latest ROE figure is --, indicating that the company has stable profitability.
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Neuroscientific Biopharmaceuticals Ltd, the total asset return on investment (ROA) is --.
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Neuroscientific Biopharmaceuticals Ltd's latest financial report to see how their gross margin is doing - currently at --.
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Neuroscientific Biopharmaceuticals Ltd, the net profit margin is --, which is a good sign for its profitability.